Clinical Trial Details

EORTC-24051-HNCG

Back to Clinical Trials Database

Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 09-May-2007
Date Step1 close: 04-Nov-2008
Data management at EORTC Yes
Design Phase 1-2
Randomized open
Targeted Sample size All Groups: 127
Treatment Radiotherapy, Drug
Fluorouracil, Carboplatin, Cisplatin, Docetaxel, Lapatinib
Study Staff
Type of cancer Head and Neck
Participating groups EORTC Head and Neck Cancer Group
Participating centers Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101
Universitair Ziekenhuis Antwerpen (Edegem, Belgium) - Inst. 117
Protocol summary http://clinicaltrials.gov/ct/show/NCT00498953
NCT number NCT00498953
EudraCT 2006-002667-33